A dual role for adeno-associated virus in human health

Abstract Adeno-associated virus (AAV) differs from most other viruses, as it requires the simultaneous presence of a helper virus for an active infection. Up to 80% of the human population is seropositive for AAV antibodies. AAV has been known to be a non-pathogenic virus and an inhibitor of carcino...

Full description

Bibliographic Details
Main Author: Natalia M Araujo
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Virology Journal
Subjects:
Online Access:https://doi.org/10.1186/s12985-023-02196-8
_version_ 1797453875727302656
author Natalia M Araujo
author_facet Natalia M Araujo
author_sort Natalia M Araujo
collection DOAJ
description Abstract Adeno-associated virus (AAV) differs from most other viruses, as it requires the simultaneous presence of a helper virus for an active infection. Up to 80% of the human population is seropositive for AAV antibodies. AAV has been known to be a non-pathogenic virus and an inhibitor of carcinogenesis caused by coinfecting viruses. However, the recent reports associating AAV infection with hepatocellular carcinoma development and the mysterious cases of acute severe hepatitis in children have challenged the idea that AAV is a harmless virus. Herein, we explore the usefulness of AAV in gene therapy and the importance of AAV as a protector or perpetrator in human carcinogenesis, ultimately reflecting on the dual role of AAV in human health.
first_indexed 2024-03-09T15:29:11Z
format Article
id doaj.art-4f5dd3ea71cb4b10995cbbdf11443948
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-03-09T15:29:11Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-4f5dd3ea71cb4b10995cbbdf114439482023-11-26T12:20:33ZengBMCVirology Journal1743-422X2023-10-012011310.1186/s12985-023-02196-8A dual role for adeno-associated virus in human healthNatalia M Araujo0Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, FIOCRUZAbstract Adeno-associated virus (AAV) differs from most other viruses, as it requires the simultaneous presence of a helper virus for an active infection. Up to 80% of the human population is seropositive for AAV antibodies. AAV has been known to be a non-pathogenic virus and an inhibitor of carcinogenesis caused by coinfecting viruses. However, the recent reports associating AAV infection with hepatocellular carcinoma development and the mysterious cases of acute severe hepatitis in children have challenged the idea that AAV is a harmless virus. Herein, we explore the usefulness of AAV in gene therapy and the importance of AAV as a protector or perpetrator in human carcinogenesis, ultimately reflecting on the dual role of AAV in human health.https://doi.org/10.1186/s12985-023-02196-8AAVHepatocellular carcinomaHepatitisChildrenGene therapy
spellingShingle Natalia M Araujo
A dual role for adeno-associated virus in human health
Virology Journal
AAV
Hepatocellular carcinoma
Hepatitis
Children
Gene therapy
title A dual role for adeno-associated virus in human health
title_full A dual role for adeno-associated virus in human health
title_fullStr A dual role for adeno-associated virus in human health
title_full_unstemmed A dual role for adeno-associated virus in human health
title_short A dual role for adeno-associated virus in human health
title_sort dual role for adeno associated virus in human health
topic AAV
Hepatocellular carcinoma
Hepatitis
Children
Gene therapy
url https://doi.org/10.1186/s12985-023-02196-8
work_keys_str_mv AT nataliamaraujo adualroleforadenoassociatedvirusinhumanhealth
AT nataliamaraujo dualroleforadenoassociatedvirusinhumanhealth